Table 1 Overview of patients enrolled within the clinical trial
Total LSCD | |||||||||
|---|---|---|---|---|---|---|---|---|---|
No. | AGE | SEX | LSCD etiology | Type | Follow-up (months) | VA before | VA after | Tx Post LEC TX | Result |
1 | 44 | M | Chemical burn | allo* auto | 41 | CF (0.014) | CF (0.014) | PK | Failed |
2 | 45 | F | Chemical burn | auto | 43 | HM (0.005) | 0,05 | - | AS, FS |
4 | 45 | M | Chemical burn | auto | 31 | CF (0.014) | <0,05 | - | Failed |
5 | 6 | M | Chemical burn | auto | 31 | HM (0.005) | LP (0) | PK | Failed |
6 | 27 | M | Aniridia | allo** | 27 | 0.053 | 0.1 | PK | AS, FS |
7 | 70 | F | Corneal ulcer | auto | 25 | LP (0) | HM (0.005) | PK | AS, FS |
8 | 29 | M | Chemical burn | auto | 25 | <0,05 | HM (0.005) | - | Failed |
10 | 33 | M | Chemical burn | auto | 19 | LP (0) | LP (0) | - | Failed |
11 | 63 | M | Iatrogenic | auto | 19 | HM (0.005) | HM (0.005) | - | AS |
13 | 31 | F | Aniridia | allo** | 48 | CF (0.014) | 0.2 | PK | AS, FS |
14 | 16 | F | Kniest syndrome | auto | 6 | LP (0) | HM (0.005) | - | AS |
15 | 6 | M | Keratitis | auto | 5 | LP (0) | LP (0) | - | Failed |
16 | 48 | M | Chemical burn | auto | 4 | CF (0.014) | 0.125 | - | AS, FS |
17 | 79 | M | Trauma | auto | 4 | CF (0.014) | CF (0.014) | - | AS |
18 | 42 | F | Viral keratitis | auto | 18 | LP (0) | HM (0.005) | PK | AS, FS |
Partial LSCD | |||||||||
No. | AGE | SEX | LSCD Etiology | Type | Follow-up (months) | VA before | VA after | Tx Post LEC TX | Result |
3 | 57 | F | Iatrogenic | auto | 39 | 0.15 | 0,16 | - | AS, FS |
9 | 44 | F | Keratitis, uveitis | auto | 24 | CF (0.014) | 0.15 | PK | AS, FS |
12 | 47 | M | Trauma | auto | 18 | 0.2 | 0.9 | - | AS, FS |